English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Curative therapy for spinal cord injury (SCI) remains elusive, however identifying options for tailored treatment strategies is in full swing. Like in the brain there are distinct regions in the adult spinal cord that harbor neural progenitor cells (NPCs) (Horner et al., 2000). This offers the possibility of recruiting these cells in reparative approaches to support endogenous spinal cord regenerative capacities. Hereby, one challenge among many others is to overcome the already restrictive microenvironment of potential endogenous NPCs, which is considerably altered by ongoing secondary lesion cascades by the initial lesion. Research addressing this aspect identified a plethora of mediators that hinder or promote neuroregeneration where at inflammatory mediators are known to play an essential role.

Chemokines and their receptors: important mediators to be aware of in neuroregenerative approaches for spinal cord injury